Compare CADL & LFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CADL | LFMD |
|---|---|---|
| Founded | 1999 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 339.8M | 330.5M |
| IPO Year | 2021 | N/A |
| Metric | CADL | LFMD |
|---|---|---|
| Price | $5.44 | $3.49 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 9 |
| Target Price | ★ $19.43 | $10.22 |
| AVG Volume (30 Days) | 943.3K | ★ 1.2M |
| Earning Date | 11-13-2025 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $250,091,814.00 |
| Revenue This Year | N/A | $13.65 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 28.78 |
| 52 Week Low | $4.25 | $3.18 |
| 52 Week High | $13.68 | $15.84 |
| Indicator | CADL | LFMD |
|---|---|---|
| Relative Strength Index (RSI) | 47.49 | 43.85 |
| Support Level | $5.45 | $3.36 |
| Resistance Level | $6.14 | $3.53 |
| Average True Range (ATR) | 0.34 | 0.22 |
| MACD | -0.05 | 0.08 |
| Stochastic Oscillator | 7.88 | 35.47 |
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.